Peter Andersen Overview

  • Investor Type
  • Angel

  • Investments
  • 4

  • Portfolio
  • 1

  • Exits
  • 1

Exits

Peter Andersen General Information

Description

Mr. Peter Andersen is an Angel Investor. Mr. Andersen served as President at Pandora Western Europe. He serves as the Board Member at Schormand.

Business Details

Primary Investor Type
Angel (individual)

Peter Andersen Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Nintx 09-Dec-2024 Early Stage VC Drug Discovery Clinical Trials - General
Nintx 04-Aug-2022 Drug Discovery Clinical Trials - General
Schormand 02-Jun-2016 Angel (individual) Clothing Generating Revenue
Schormand 11-Dec-2015 Early Stage VC Clothing Generating Revenue

Peter Andersen Exits (1)

Company Name Exit Date Exit Type Exit Size
Schormand 01-Feb-2018

Peter Andersen Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Peter Andersen Co-Investors (7)

Name With Exits Lead Partner Series Industry
Adeste AS 1 Series chart Industry bar
Guilherme Leal Series chart Industry bar
MOV Investimentos Series chart Industry bar
Mare Investimentos Series chart Industry bar
Pitanga Series chart Industry bar

Peter Andersen FAQs

  • Who is Peter Andersen?

    Peter Andersen is an angel Investor who has made 4 investments.

  • What kind of investor is Peter Andersen?

    Peter Andersen is an angel investor.

  • What does Peter Andersen do?

    As an angel investor, Peter Andersen invests personal money into promising companies, typically in exchange for equity.

  • What has Peter Andersen invested in?

    Peter Andersen has made numerous investments in companies like Nintx and Schormand within the Drug Discovery and Clothing industries.

  • What has Peter Andersen invested in recently?

    Peter Andersen's latest investment was on 09-Dec-2024 in Nintx, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process